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Cytokine-activated STAT proteins dimerize and
bind to high-affinity motifs, and N-terminal domain-
mediated oligomerization of dimers allows tetramer
formation and binding to low-affinity tandem motifs,
but the functions of dimers versus tetramers are
unknown. We generated Stat5a-Stat5b double
knockin (DKI) N-domain mutant mice in which
STAT5 proteins form dimers but not tetramers, iden-
tified cytokine-regulated genes whose expression
required STAT5 tetramers, and defined dimer versus
tetramer consensus motifs. Whereas Stat5-deficient
mice exhibited perinatal lethality, DKI mice were
viable; thus, STAT5 dimers were sufficient for
survival. Nevertheless, STAT5 DKI mice had fewer
CD4+CD25+ T cells, NK cells, and CD8+ T cells, with
impaired cytokine-induced and homeostatic prolifer-
ation of CD8+ T cells. Moreover, DKI CD8+ T cell
proliferation after viral infection was diminished and
DKI Treg cells did not efficiently control colitis.
Thus, tetramerization of STAT5 is critical for cytokine
responses and normal immune function, establishing
a critical role for STAT5 tetramerization in vivo.
INTRODUCTION
Signal transducers and activators of transcription (STAT
proteins) play vital roles in modulating gene expression in
response to cytokines, interferons, and various growth factors
and are critical for development and cellular function (Leonard
and O’Shea, 1998; Levy and Darnell, 2002). Cytokines and inter-
ferons activate JAK kinases, which in turn phosphorylate key
tyrosines on their receptors, allowing the binding of STAT
proteins via their SH2 domains to these phosphotyrosine dock-
ing sites. The STAT proteins in turn are then tyrosine phosphor-586 Immunity 36, 586–599, April 20, 2012 ª2012 Elsevier Inc.ylated, thus allowing their dimerization (Leonard and O’Shea,
1998; Levy and Darnell, 2002). Additionally, at least some STAT
proteins can form tetramers via N-terminal domain-mediated
interactions, with binding to tandem binding sites (Vinkemeier
et al., 1996; Xu et al., 1996), but the role of STAT tetramerization
in vivo is poorly understood. Here, we have investigated the
role of STAT5A and STAT5B tetramerization in vivo.
Of the seven mammalian STAT proteins, STAT1, STAT2,
STAT3, STAT4, STAT5A, STAT5B, and STAT6, STAT5A and
STAT5B are particularly similar, with 91% amino acid identity
in humans and mice. STAT5A and STAT5B are encoded by
head-to-head genes on human chromosome 17q11.2 (Lin
et al., 1996) and mouse chromosome 11 (Copeland et al.,
1995) and can be activated by prolactin, growth hormone, IL-2,
IL-3, IL-5, IL-7, IL-9, IL-15, IL-21, granulocyte-macrophage
colony-stimulating factor, erythropoietin, thrombopoietin, and
thymic stromal lymphopoietin (Leonard and O’Shea, 1998;
Rochman et al., 2009). Stat5a/mice have defective mammary
gland development and lactogenesis due to defective prolactin
signaling (Liu et al., 1997), whereas Stat5b/ mice have a loss
of sexually dimorphic growth due to defective growth hormone
signaling (Udy et al., 1997). Mice with hypomorphic expression
of truncated forms of both STAT5A and STAT5B exhibit more
severe defects in prolactin and growth hormone signaling
(Teglund et al., 1998), as well as defective erythropoiesis (Soco-
lovsky et al., 1999), and complete deletion of both Stat5a and
Stat5b results in >99% perinatal lethality due to severe anemia
and potentially other defects (Cui et al., 2004).
In the immune system, both Stat5a/ (Nakajima et al., 1997)
and Stat5b/ (Imada et al., 1998) mice exhibit decreased IL-2-
induced IL-2 receptor a chain (IL-2Ra) expression. STAT5A
and STAT5B have both overlapping and distinctive functions,
with STAT5B playing a more critical role for natural killer (NK)
cell development and function (Imada et al., 1998; Moriggl
et al., 1999). The few Stat5a/Stat5b/ mice that survive have
defective development of CD8+ T cells, gd T cells, NK cells, and
B cells (Yao et al., 2006).
Activated STAT1 STAT3, STAT4, STAT5A, and STAT5B bind
to TTCN3GAA g-interferon-activated sequence (GAS) motifs as
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O’Shea, 1998). For at least STAT1, STAT4, and STAT5,
N-terminal interactions between STAT dimers allow binding to
two or more tandem GAS motifs as higher-order complexes
(John et al., 1996; John et al., 1999; Meyer et al., 1997; Vinkeme-
ier et al., 1996; Vinkemeier et al., 1998; Xu et al., 1996). On the
basis of the structure of the STAT4 N-domain (Chen et al.,
2003), we identified corresponding residues in STAT5 pro-
teins and generated tetramer-deficient knockin (KI) mice for
Stat5a and/or Stat5b. In contrast to perinatal lethality in
Stat5a/Stat5b/ mice, DKI mice were viable, underscoring
the importance of STAT5 dimers and indicating that STAT5 tetra-
mers are not required for survival. Nevertheless, gene expres-
sion analysis revealed defective expression of a subset of genes
in IL-2-induced DKI T cells. We also used ChIP-Seq method-
ology to identify genome-wide STAT5A and STAT5B dimer and
tetramer binding sites and established consensus binding
motifs for STAT5A and STAT5B, including optimal spacing
between tandemly linked GAS motifs for tetramers. Correlating
ChIP-Seq and gene expression data allowed us to identify genes
whose expression is regulated by STAT5 tetramers but not
dimers, thus clarifying the role of STAT5 tetramerization in vivo.
Moreover, whereas STAT5 dimers but not tetramers were
essential for viability and normal growth, tetramer-deficient
mice had decreased CD4+CD25+ T cells and NK cells, dimin-
ished cytokine-induced proliferation of DKI CD8+ T cells,
increased apoptosis of DKI CD8+ T cells upon IL-2-withdrawal,
and impaired homeostatic proliferation of DKI CD8+ T cells
in vivo. DKI mice also exhibited defective expansion of viral-
specific DKI CD8+ T cells after infection with lymphocytic chorio-
meningitis virus (LCMV) or adenovirus 5 and had diminished
regulatory T (Treg) cell function as evaluated by suppression of
colitis. These data underscore key roles of STAT5 tetrameriza-
tion in normal immune function, with most of the STAT5
tetramer-regulated genes requiring STAT5 tetramers for their
optimal expression. These findings have implications for other
STAT proteins that can form tetramers, with potential implica-
tions for other transcription factors as well.
RESULTS
Generating STAT5 Tetramer-Deficient Mice
Our laboratory previously showed that STAT5A and STAT5B
homodimers share core TTC(T/C)N(G/A)GAA GAS motifs and
that STAT5A tetramers often bind to imperfect tandem GAS
motifs not retaining a consensus TTCN3GAA motif (Soldaini
et al., 2000). However, that study used a DNA binding site selec-
tion analysis with oligonucleotides containing only 26 nucleo-
tides of random sequence, thus limiting information on optimal
spacing between tandem motifs. Here, we sought to identify
the range of STAT5 tetramer-regulated genes to characterize
the basis for tetramer binding and moreover to elucidate the
biological role of STAT5 tetramerization in vivo.
Analysis of the STAT1 and STAT4 N-domain crystal structures
revealed that M28, F77, and L78 (STAT1) and M28, L77, and L78
(STAT4) were required for tetramer formation (Chen et al., 2003).
We aligned the N-domains of all mouse STAT proteins except
STAT2 and identified I28, F81, and L82 as the corresponding
residues in STAT5A and STAT5B (Figure 1A and Figure S1Aavailable online). Mutation of these residues to alanines, alone
or in combination, did not affect binding to the b-casein probe
(Figure 1B forSTAT5AandFigure 1C forSTAT5B),whichcontains
a singleGASmotif and binds only STAT5dimers, but it abrogated
tetrameric binding to the IL-2Ra promoter PRRIII GAScn probe
(Figure 1D for STAT5A and Figure 1E for STAT5B), which favors
tetrameric binding (John et al., 1999). Interestingly, dimeric
binding increased when tetrameric binding was prevented,
particularly for STAT5B (Figures 1D and 1E). Thus, I28, F81, and
L82 are required for STAT5 tetramer but not dimer formation. As
expected, the tetramer-defective mutant STAT5 proteins ex-
hibited similar off-rates to those observed for WT STAT5 protein
with the b-casein probe (Figure 1F), which only binds dimers.
Interestingly, the off-rate of mutant STAT5 was slightly increased
for dimer binding to the IL-2Ra GAScn probe (Figure 1G), which
can bind tetramers as well as dimers. As anticipated, when an
increasing amount of tetramer-defective STATB protein was
mixedwithafixedamountofWTSTAT5Bandadded toaconstant
amount of probe, the amount of dimer binding increased, as
would be expected by the addition of more dimer protein (Figure
1H). Conversely, the amount of both tetramer and dimer
increased when an increasing amount of WT STATB was mixed
with a fixed amount of the mutant STAT5B protein, as would be
expected by the addition of more tetramer and dimer (Figure 1H).
To study the role of STAT5 tetramerization in vivo, we targeted
the I28 and F81 codons in Stat5a (Figure S2A) and Stat5b
(Figure S2B) and generated single and double knockin (DKI)
ESCs (Figure S2C for Stat5a, Figure S2D for Stat5b, and Fig-
ure S2E for targeting of both Stat5 genes), which we used to
generate KI mice. Expression of WT and mutant Stat5 alleles
was similar (Figure 2A), and IL-2 induced rapid and sustained
tyrosine phosphorylation of STAT5 proteins with similar kinetics
inWTandDKITcells (Figure2B). Thus,disruptingSTAT5 tetramer
formation did not affect STAT5 protein levels or the kinetics of
IL-2-induced phosphorylation. We isolated nuclear extracts and
used EMSAs to confirm that the DKI T cells had normal IL-2-
induced STAT5 binding to a probe (b-casein) that selectively
binds dimers but not to a probe (Il2ra and Lta) that selectively
binds tetramers (Figure 2C). Moreover, Stat5a KI, Stat5b KI, and
Stat5a and Stat5b DKI mice were viable, were normal in weight
(Figure S2F), and had normal peripheral leukocyte numbers (Fig-
ureS2G).STAT5 tetramer-deficient neonates hadmilddecreases
in hematocrit, red blood cell numbers, and hemoglobin levels, but
levels normalized by adulthood (Figure S2H).
Decreased Peripheral CD8+, and NK Cells in DKI Mice
In contrast to the severely impaired T cell development in mice
lackingStat5a and Stat5b (Yao et al., 2006), DKI mice had normal
numbers of thymocytes, including double positive (DP), double
negative (DN), and CD4+ and CD8+ single positive (SP) subpop-
ulations (Figures 2D and 2E). Interestingly, the DKI mice had
a slightly increased splenic B:T cell ratio (Figure 2F), but total
numbers of splenic B and T cells were similar to WT mice (Fig-
ure 2G). The CD4:CD8 ratio was modestly increased (Figure 2H),
with slightly decreasedCD8+ T cells (p < 0.05) and a trend toward
slightly increased CD4+ T cells (Figure 2I). NKT cell numbers
were normal, but NK cells were significantly decreased (Figures
2J and 2K), indicating a requirement for STAT5 tetramers for NK
cell development. As expected, development of Mac-1+, Gr.1+Immunity 36, 586–599, April 20, 2012 ª2012 Elsevier Inc. 587
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Figure 1. I28, F81, and L82 in the N-Domains
of STAT5A and STAT5B Are Required for
Tetramer Formation
(A) Schematic of conserved amino acids required
for tetramer binding in STAT1, STAT4, STAT5A,
and STAT5B, based on data for STAT1 and STAT4
(Chen et al., 2003). The numbers above (for STAT1
and STAT4) or below (for STAT5A and STAT5B)
indicate the amino acid positions.
(B–E) EMSAs were performed using [32P]-labeled
b-casein (B) and (C) or IL-2Ra GAScn (D) and (E)
probes and nuclear extracts from 293T+ cells
transfected with plasmids directing expression of
IL-2Rb, gc, and JAK3 as well as pCi (B–E, lane 1),
pCi-Stat5a (B and D, lanes 2 to 7), or pCi-Stat5b (C
and E, lanes 2 to 5), as indicated. Arrows indicate
dimer or tetramer binding.
(F and G) Off-rates of WT and mutant STAT5
proteins from a site from the b-casein gene, which
binds as dimers (F) or a site from the IL-2Ra gene,
which binds both STAT5 tetramers and dimers (G).
(H) Titration of binding WT and mutant STAT5B
proteins. The experiments in (B)–(H) were per-
formed twice.
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Critical Role of STAT5 Tetramers In Vivoand Ter119+ cells was normal (Figure S2I). Thus, STAT5A and
STAT5B dimers are sufficient for normal thymic development,
whereas tetramers are required for normal numbers of peripheral
CD8+ T and NK cells.
Previously, STAT5 tetramers were shown to be important for
IL-2-induced IL-2Ra (CD25) promoter activity (John et al.,
1996; Kim et al., 2001). Consistent with this, IL-2-induced IL-
2Ra expression was abrogated in CD4+ and CD8+ splenic
T cells from DKI mice and slightly decreased in Stat5a KI and
Stat5b KI T cells (Figure 3A). The defect tended to be greater in
Stat5b KI mice, consistent with greater lymphoid abnormalities
in Stat5b/ (Imada et al., 1998) than in Stat5a/ (Nakajima
et al., 1997) mice.
IL-2-Regulated Genes Whose Expression Requires
STAT5 Tetramers
Using Affymetrix arrays, we next compared gene expression
profiles inWT andDKI splenic T cells that were preactivated, res-588 Immunity 36, 586–599, April 20, 2012 ª2012 Elsevier Inc.ted, and restimulated with IL-2. In WT
T cells, we identified 5395 mRNAs whose
expression had a fold change (FC) >1.5-
fold, with <20% false discovery rate
(FDR) (Figure 3B), with 1690, 2102, and
2137 mRNAs induced and 875, 1489,
and 1796 mRNAs suppressed at 2, 6,
and 17 hr by IL-2, respectively (Figure 3B,
bar graph; Table S1). Among the 5395
IL-2 regulated mRNAs, 506 (9.4%)
were significantly altered (FC R 1.5) in
Stat5a-Stat5b DKI T cells relative to WT
cells (Figure 3C and Table S2), with
more repressed than induced genes in
the DKI T cells (Figure 3C, bar graph).
These included genes encoding cyto-
kines and molecules that regulate cyto-kine signaling and functions (e.g., Il24, Il2ra, Ifng, Lif, Lta, Osm,
Tnf, Fyn, Fes, Rgs1, Cish, Socs1, Socs2, Socs3, Myc, Mix1,
Bcl2, Cdk6, Fasl, Irf4, Irf8, Foxo3a, Foxp1, and Nfkb1; Table
S3). For some of these genes, we used RT-PCR to confirm
that IL-2-induced expression was essentially abolished (e.g.,
Socs2 and Lta) or greatly diminished (e.g., Il2ra, Ifng, Il24, Tnf,
Osm, and Cdk6) in DKI T cells (Figure 3D). IL-4 can also induce
Il2ra and Socs2 mRNA in WT T cells, but as expected given
that IL-4 primarily activates STAT6 rather than STAT5, the induc-
tion of these genes by IL-4 was not significantly affected in DKI
T cells (Figure 3E), indicating the specificity of the defect. Inter-
estingly, in WT T cells, IL-2-induced genes tended to have
more significant p values than IL-2 suppressed genes, but in
DKI cells, the repressed genes had lower p values (Figure S3),
suggesting a dominant role for STAT5 tetramers in gene induc-
tion rather than repression in T cells, particularly for genes
involved in gene regulation (Figure S3 and Tables S1 and S2).
Thus, a subset of IL-2-regulated genes is specifically regulated
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Figure 2. Normal Expression and Tyrosine
Phosphorylation of STAT5 Proteins but
Decreased Peripheral NK and CD8+ T Cells
in DKI Mice
(A) Immunoblots of STAT5A and STAT5B expres-
sion in splenic T cells from Stat5a KI (lane 2),
Stat5b KI (lane 4), and Stat5a-Stat5b DKI (lane 6)
mice versus WT (lanes 1 and 3), and heterozygous
Stat5a-Stat5b DKI mice (lane 5). Actin levels are
also shown as a loading control.
(B) Representative immunoblots of two experi-
ments showing tyrosine phosphorylated and total
STAT5 protein in WT (upper panels) and DKI (lower
panels) splenic T cells stimulated by IL-2 (100 U/
ml) for the indicated times. Prior to IL-2 stimulation,
cells were preactivated by plate-bound anti-CD3
(2 mg/ml) and soluble anti-CD28 (1 mg/ml) for
2 days and rested overnight.
(C) EMSA for dimeric STAT5 binding (b-casein
probe, lanes 2 and 4) and tetrameric STAT5 binding
(for Il2ra GAScn, lanes 6 and 8 and Lta GAS, lanes
10 and 12) with nuclear extracts from IL-2-treated
WTandDKI T cells. Dimer (arrowwith solid line) and
tetramer (arrow with dash line) complexes are indi-
cated. This experiment was performed three times.
(D and E) CD4 and CD8 flow cytometric profile of
thymocytes from WT and DKI mice (n = 8; D) with
cell numbers indicated (E).
(F–K) Flow cytometric profiles and cellularity of
spleens from WT and DKI mice.
(F–I) WT and DKI splenocytes were isolated and
stainedwith anti-CD3 versus anti-B220 (F andG) or
anti-CD4 versus anti-CD8 (H and I) (n = 20).
(JandK)Splenocytes fromWTandDKImice (n=16)
were stained as TCRb+CD1d-PBS57+ NKT cells or
CD3NK1.1+CD122+ NK cells (J) and total cells
determined (K).
Immunity
Critical Role of STAT5 Tetramers In Vivoby STAT5 tetramers in T cells, and these genes are preferentially
induced rather than repressed by IL-2.
STAT5 Dimer and Tetramer Consensus-Binding Sites
To identify motifs for STAT5A and STAT5B dimer and tetramer
binding, we used ChIP-Seq and WT and DKI T cells cultured
with or without IL-2 for 1 hr. Using MACS (model-based analysis
for ChIP-Seq [Zhang et al., 2008)), we compared untreated
versus IL-2-induced WT samples after subtracting background
IgG control levels (see Experimental Procedures and Figure S4A)
and identified 16,957 STAT5A and 17,418 STAT5B sites (Table
S4), including those binding to both dimers and tetramers. The
genome-wide distributions of STAT5A and STAT5B binding sites
were similar (Figure S4B). Analysis of STAT DKI ChIP-Seq data
revealed 14,770 STAT5A and 12,568 STAT5B sites that
presumptively only bind to dimers (Table S4). Interestingly, as
compared to the distribution of all STAT5A and STAT5B sites
(Figure S4B), dimers somewhat preferentially bound in promoterImmunity 36, 586–5and 50 UTR regions, with slightly
decreased frequency in intergenic and
30 UTR regions and exons (Figure S4C).
To de novo discover motifs recognized
by STAT5A and STAT5B dimers, we
analyzed the 10% top sites in DKI datasets on the basis of the most significant p values by using
MEME (Bailey and Elkan, 1994). As expected, we defined almost
identical motifs for STAT5A (Figures 4A and S4D) and STAT5B
(Figures 4B and S4E), with favored binding to canonical
TTCN3GAA GAS motifs; nucleotides at positions 1, 3, 7, and 9
were the most conserved.
To identify motifs for STAT5 tetramers, we analyzed sites
present in IL-2-induced WT samples that were absent or greatly
diminished in IL-2-induced DKI samples (Figure S4A). We
selected sequences with canonical GAS or GAS-like motifs
with only single mismatches (Figures S4F–S4H). Approximately
50% of these sites had a second GAS motif, and we defined
the consensus STAT5 tetramer motif as T(T/A)C(T/C)N(A/G)
G(A/T)AN2-15(T/C)(T/A)(C/T)(T/C)N(A/G/T)G(A/T)A (Figure 4C),
with similar spacing between the GAS and/or GAS-like motifs
for STAT5A (Figure 4D) and STAT5B (Figure 4E). As expected,
the second (more 30) GAS motif was typically more degenerate
than the first (Figure 4C) and more degenerate than the motifs99, April 20, 2012 ª2012 Elsevier Inc. 589
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Figure 3. Altered Gene Expression in DKI T Cells
(A) Preactivated splenic T cells were rested overnight and restimulated with IL-2 for 1 day prior to determining CD25 expression in CD4+ and CD8+ T cells. IL-2-
induced CD25 expression levels are indicated as mean fluorescence (MFI). Isotype control (IgG), IL-2, and untreated samples are shown in gray, red, and blue,
respectively. This experiment was performed three times.
(B) On the left is a hierarchical clustering analysis of gene expression profiles regulated by IL-2 inWT T cells. Also shown is a pie graph of the number ofmRNAs not
regulated (red) or regulated (blue) by IL-2. For IL-2-regulated mRNAs, the linked bar graph indicates the number of mRNAs whose expression was induced (open
bars) or repressed (solid bars) at each time point.
(C) Shown on the left is the hierarchical clustering analysis of IL-2-regulated mRNAs in DKI as compared with WT T cells. Also shown is a pie graph of the number
of IL-2-regulated mRNAs whose expression was not affected (orange) or affected (blue) in DKI T cells. For the 506 mRNAs whose expression was affected, the
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Tetramer binding was facilitated with a spacing of 6–7 bp,
decreased at 8–9 bp, and most favored at 11–12 bp; another
slight increase occurred at 15–16 bp, followed by a decline,
with essentially undetectable tetramer binding at spacing
>22 bp. More than 76% of the sites had a spacing of 6–17 bp
between the GAS or GAS-like motifs, with 11.8% of motifs
having spacing of 6–7 bp, 30.1% spacing of 11–12 bp, and
11.5% spacing of 16–17 bp. Our earlier DNA binding selection
assay revealed a peak at 6–7 bp (Soldaini et al., 2000), but the
short random oligonucleotides used in that analysis did not allow
the identification of the optimal spacing of 11–12 bp. Interest-
ingly, as compared to dimer binding sites (Figure S4C), STAT5
tetramer binding sites were relatively enriched in introns and
decreased in the promoter regions (Figure 4F).
Comparing gene expression and ChIP-Seq data from WT and
DKI cells revealed that 2,266 of the IL-2-regulated genes con-
tained STAT5 dimer or tetramer binding sites. More of these
were induced (1413) than repressed (859) by IL-2 in WT T cells.
Genes whose IL-2-induced expression was significantly altered
in Stat5a-Stat5b DKI T cells and that exhibited lower ChIP-Seq
binding than in WT T cells presumptively were directly regulated
by STAT5 tetramers. Of the 506 genes whose regulation by IL-2
was significantly increased or decreased in DKI T cells, 417 cor-
responded togenes inRefSeqandcouldbeanalyzed for tetramer
bindingsites.Of these, 105hadSTAT5 tetramermotifswithin 5kb
50 of the TSS or within the gene body. These genes were all ex-
pressed at lower levels in DKI than in WT T cells, whereas genes
whose expression was significantly higher in DKI T cells did not
contain STAT5 tetramer binding sites. Thus, STAT5 tetramers
preferentially mediate gene induction rather than repression in
T cells.
On the basis of ChIP-Seq analysis (Figure 4G), we further eval-
uated in vitro binding by EMSA (Figure 4H) to probes containing
tandemly linked GAS and GAS-like motifs and corresponding to
sites that appear to exhibit ‘‘good,’’ ‘‘moderate,’’ or ‘‘weak’’
binding as tetramers. By ChIP-Seq, the Lta gene preferentially
bound tetramers, and correspondingly, a probe from this gene
predominantly bound tetramers and exhibited only weak binding
to tetramer-defective STAT5 proteins. Similar results were
observed with probes corresponding to the Il2ra GAScn, Il24
GAS, and a tetramer binding site in the first intron of Il2ra gene
that we denote as Il2ra GAS12, but these probes also bound
dimers, as was especially apparent when tetramer-defective
STAT5 proteins were used. The Cradd GAS probe mainly bound
dimers, to a lesser extent ‘‘2x dimers’’ (two dimers that simulta-
neously yet independently bind without requiring an N-domain
interaction between them), and exhibited least binding to tetra-
mers. Therefore, it is likely that both the nucleotide composition
of the GAS and GAS-like motifs and the spacing between GAS
and GAS-like motifs influence whether a given sequence binds
tetramers and/or 23 dimers or just dimers. Thus, we not onlylinked bar graph indicates the number of genes whose expression was higher (ope
five replicates of WT and DKI splenic T cells were analyzed for each treatment.
(D and E) Validation of STAT5 tetramer-dependent IL-2-induced gene expressio
experiments described in (D) were performed four times and those described in (E
on the cycle number for Rpl7 primers, given that Rpl7 expression was constant un
samples of a representative experiment.discovered a vital role for tetramers in regulating a set of IL-2-
induced genes but also defined the motifs that mediate STAT5
dimer and tetramer binding.
STAT5 Tetramers Are Required for CD8+ T Cell Survival
and Proliferation
Because many genes regulated by STAT5 tetramers control
proliferation and cell cycle progression (Table S3), we hypothe-
sized that DKI cells would have diminished cytokine-mediated
proliferation. Indeed, IL-2-induced [3H]-thymidine incorporation
was decreased (Figure 5A). High-dose IL-2 (100 U/ml, 2 nM),
which titrates most IL-2Rb/gc intermediate affinity IL-2 recep-
tors, or even 500 U/ml (10 nM), could not correct this defect (Fig-
ure 5A), indicating that it was not solely due to decreased IL-2Ra
expression and that other STAT5 tetramer-dependent genes
must be involved. Anti-CD3 + anti-CD28-induced proliferation
of DKI cells was almost normal (Figure 5B), indicating that there
is no intrinsic proliferative defect in these cells.
We next compared the proliferative response of CD4+ and
CD8+ T cells to other gc family cytokines that use STAT5. As
expected, WT CD4+ T cells only weakly proliferated in response
to IL-2, IL-7, IL-15, or combinations of these cytokines, but no
proliferation was observed in DKI CD4+ T cells (Figure 5C). In
contrast to WT CD4+ T cells, proliferation of WT CD8+ T cells
was readily seen with IL-2, IL-15, IL-2 + IL-7, IL-2 + IL-15,
IL7 + IL-15, or a combination of all three cytokines. CFSE dilution
was markedly decreased in DKI CD8+ T cells in response to all
combinations of cytokines (Figure 5C). Thus, STAT5 tetramers
are vital for proliferation in response to these cytokines. Differ-
ences in receptor expression could not explain these diminished
responses, given that IL-2Rb and IL-7Ra expression was only
minimally lower in the DKI CD8+ T cells (Figure 5D). Consistent
with the in vitro proliferative defect of DKI CD8+ T cells to these
cytokines, IL-2- and IL-15-induced expression of genes involved
in cell cycle progression and proliferation was significantly lower
in DKI than in WT CD8+ T cells (Figure 5E and Tables S5A–S5C).
In addition, there was no apparent increase in cell death in
freshly isolated DKI CD4+ or CD8+ T cells (Figure S5A) or in
response to IL-2, IL-7, and/or IL-15 (Figures S5B and S5C),
even though BCL2 expression was moderately lower in these
cells (Figure S5D). However, DKI CD8+ T cells were more
susceptible thanWT cells to apoptosis after IL-2 withdrawal (Fig-
ure 5F, left panel) and had decreased BCL2 levels (Figure 5F,
right panel), indicating that STAT5 tetramers are required for
lymphocyte viability as well as proliferation.
We also examined the frequency of CD4+ and CD8+ memory
phenotype CD44hiCD62hi T cells and found they were less
abundant, whereas the frequency of naive phenotype
CD44loCD62hi T cells was greater in DKI than in WT cells (Fig-
ure S5E). When cultured in medium alone, the kinetics of naive
CD4+ T cell death was relatively similar in WT and DKI mice,
although the DKI cells reproducibly had a slightly faster declinen bars) or lower (solid bars) in the DKI T cells. For the experiments in (B) and (C),
n (D) and STAT5 tetramer-independent IL-4-induced gene expression (E). The
) were performed twice. The cDNA inputs were normalized after RT-PCR based
der our experimental conditions. Shown are the relative expression of triplicate
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Figure 4. Distribution of STAT5 Binding Sites and STAT5 Dimer and Tetramer Motifs
(A and B) Consensus dimer motifs for STAT5A (A) and STAT5B (B). The pie graphs show the top ten binding motifs for STAT5A (A) and STAT5B (B), as detailed in
Figure S4D and S4E.
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Critical Role of STAT5 Tetramers In Vivoin viability (Figure S5F). This was more evident in naive DKI CD8+
T cells (Figure S5G), consistent with an increased apoptosis of
DKI CD8+ T cell after IL-2 withdrawal (Figure 5F). In the presence
of IL-7, however, both WT and DKI naive CD4+ (Figure S5F) and
CD8+ (Figure S5G) T cells were similarly resistant to cell death.
This correlated with similar IL-7-induced BCL2 levels in WT
and DKI CD4+ and CD8+ T cells, although the levels in DKI cells
were slightly lower than in WT cells (Figure S5H).
Because of the in vitro proliferative defect in DKI cells (Fig-
ure 5C), we next evaluated homeostatic proliferation of CD8+
T cells after transfer into Rag2/ lymphopenic hosts. In both
spleen and lymph nodes, we found decreased cell division and
lower accumulation of adoptively transferred DKI cells than WT
T cells (Figure 5G); this was due to defective expansion of
CD8+ T cells (Figure 5G). We also evaluated the ability of adop-
tively transferred WT or DKI cells to compete with repopulating
endogenous cells in sublethally irradiated C57BL/6 mice. CFSE
dilution was again slower in the DKI cells (upper half, Figure 5H)
and repopulation of total T cells and CD8+ T cells was even more
defective, with a suggestion of a CD4+ T cell defect in lymph
nodes as well (lower half, Figure 5H). These results together
underscore a critical role of STAT5 tetramers for CD8+ T cell
proliferation and cell cycle progression in vivo.
STAT5 Tetramers Are Required for Normal
LCMV-Induced CD8+ T Cell Expansion
Having found key roles for STAT5 tetramers in CD8+ T cell pro-
liferation, we next used LCMV (Armstrong strain) infection to
investigate the CD8+ T cell activation program in vivo (Kaech
et al., 2002), evaluating early and late CD8+ T cell responses
(days 8, 15, 30, 45, and 80). Both the frequency (Figures 6A
and 6B) of CD44hi activated (Figure 6B, upper panel) and virus-
specific (DbGP33+) (lower panel) CD8+ T cells were lower in
DKI than in WT mice, especially early after infection, indicating
that STAT5 tetramers are more important for the early CD8+
T cell activation and expansion phases than for the late memory
development and maintenance phases. In addition, the number
of LCMV-specific (DbGP33+ and DbGP276+) CD8+ T cells in
lymphoid (spleen) and non-lymphoid (liver and lung) tissues of
DKI mice were significantly lower than in WT mice at day 8
(Figure 6C). Despite this difference in the number of CD8+
T cells, both WT and DKI CD8+ T cells produced similar levels
of TNFa and IFNg in response to multiple LCMV epitopes (Fig-
ure 6D), indicating that STAT5 tetramers regulate their expansion
but have little or no effect on their function. Similarly, DKI mice
vaccinated with recombinant adenovirus serotype 5 encoding
LCMV glycoprotein had fewer total and CD44hi activated (Fig-
ure S6A), as well as antigen-specific CD8+ T cells (Figure S6B).(C) Consensus tetramer motif for STAT5A and STAT5B.
(D and E) Spacing distribution between tandemly linked GAS or GAS-like motifs
(F) Genome-wide distributions of STAT5A (top) and STAT5B (bottom) tetramer
according to Ref Seq data base (February 2006 assembly), and promoters defin
(G) STAT5 binding motifs for LtaGAS, Il2raGAScn, Il24GAS, Il2raGAS12, and Cra
from WT (red and green) or DKI (blue and magenta) T cells immunoprecipitated
graphs are the sequences of the probes for Lta GAS (1), Il2ra GAScn (2), Il24 G
underlined and mismatches are in lower case.
(H) EMSA with WT or tetramer-defective mutant STAT5B proteins and GAS motifs
dimer, dimers, and free probes are indicated on the basis of mobility and wheth
performed three times.Thus, STAT5 tetramers are required for antigen-specific expan-
sion of activated CD8+ T cells in two different in vivo viral model
systems.
STAT5 Tetramers Are Required for Treg Cell
Suppression in a Colitis Model
IL-2Ra expression is critical for development of CD4+Foxp3+
Treg cells and IL-2 promotes the expansion, maintenance, and
immunosuppressive function of these cells in vivo (Campbell
and Koch, 2011). As shown above, STAT5 tetramer formation
is vital for IL-2-induced IL-2Ra expression, and indeed, there
were fewer CD4+CD25+ T cells in DKI spleens (Figure 7A; top
row of Figure 7B), but surprisingly, the numbers of CD4+Foxp3+
Treg cells were similar in WT and DKI spleens (Figure 7A; bottom
row of Figure 7B). Strikingly, although the percentage of CD4+
T cells expressing low levels of CD25 was similar in STAT5 DKI
and WT littermates (4.95% versus 5.49%), the DKI mice had
essentially no CD4+ T cells with the highest expression of
CD25 (0.04% versus 1.23%) (Figure 7B, top row). We therefore
investigated Treg cell function by using an adoptive transfer
colitis model (Powrie et al., 1994). Rag2/ mice adoptively
transferred with WT naive CD4+ (CD45RBhiCD25) cells alone
stopped gaining weight at week 4, and those cotransferred
with DKI Treg (CD45RBloCD25+) cells stopped gaining weight
at week 5 posttransfer, whereas mice coreceiving WT Treg cells
gained weight up to week 8 (Figure 7C). Correspondingly, the
inflammation scores (Figure 7D), inflammatory infiltrates histo-
logically (Figure 7E), and the frequency and number of total
CD4+ T cells, CD4+IFNg+, and CD4+IL-17+ cells (Figures 7F
and 7G) in the colons of mice receiving WT Treg cells were lower
than in mice receiving DKI Treg cells, showing that DKI Treg cells
have defective function in vivo.
DISCUSSION
STAT protein dimer formation is necessary for mediating DNA
binding and transcription of the target genes (Darnell, 1997),
and STAT dimers can additionally oligomerize to form tetramers
or higher-order complexes via their N-domains, allowing binding
to tandemly linked GASmotifs that have been found in a range of
genes, including, for example, those encoding IFNg, IL-2Ra,
perforin, CIS, and GlyCam1 (Hou et al., 2003; John et al., 1996;
John et al., 1999; Meyer et al., 1997; Verdier et al., 1998; Xu
et al., 1996; Yamamoto et al., 2002), but the relative importance
of STAT dimers versus tetramers heretofore has not been ad-
dressed in vivo.
In this study, we identified and mutated key residues re-
quired for STAT5 tetramerization and generated Stat5a-Stat5bfor STAT5A (D) and STAT5B (E).
binding sites. 50 UTR, 30 UTR, promoter, and intergenic regions were defined
ed as 5 kb upstream of TSS.
ddGAS identified by ChIP-Seq analysis. Color-coded lines indicate chromatin
with anti-STAT5A (red and blue) and STAT5B (green and magenta). Below the
AS (3), Il2ra GAS12 (4), and Cradd GAS (5); the GAS and GAS-like motifs are
from Lta, Il24, Il2ra, and Cradd, identified by ChIP-Seq analysis. Tetramer, 23
er a given probe binds to mutant STAT5B protein. The experiment in (H) was
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Figure 5. STAT5 Tetramers Are Required for Cytokine-Dependent CD8+ T Cell Proliferation, Survival, and Homeostatic Proliferation
(A and B) Proliferation of WT and STAT5 DKI T cells in response to IL-2 (A) or TCR (B) stimulation. Shown is one of three (A) or two (B) experiments for
[3H]-thymine incorporation assay of purified mouse splenic T cells from STAT5 DKI mice and WT littermates (n = 3) cultured with IL-2 (A) or of anti-CD3 + anti-
CD28 (B).
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Figure 6. Significantly Decreased Virus-
Specific CD8+ T Cell Expansion in STAT5
DKI Mice after Acute LCMV Infection
(A) Representative FACS profiles. Gating was
on total lymphocytes. Shown is the frequency of
GP33+ CD8+ T cells in WT and DKI mice at indi-
cated times after infection.
(B) The frequency of CD44hi and LCMV GP33-
specific CD8+ T cells in blood was analyzed by
flow cytometry. The experiment was repeated
twice and data were pooled (error bars are SEM,
with n = 14–18 for each group and at each time
point).
(C) The total number of GP33+ and GP276+ CD8+
T cells in spleen, liver, and lung was quantified
by tetramer staining 8 days post infection.
(D) TNF-a and IFN-g production in virus-specific
CD8+ T cells at day 8 postinfection. FACS profiles
of intracellular cytokine staining in CD8+ T cells are
representative of seven independent analyses
performed after restimulation with the indicated
LCMV peptides.
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Critical Role of STAT5 Tetramers In Vivotetramer-deficient DKI mice. In contrast to the perinatal
lethality and severely defective lymphoid development in
Stat5a/Stat5b/ mice (Cui et al., 2004; Yao et al., 2006), our
results establish that STAT5 tetramers are dispensable for sur-
vival of mice and thymic development. Nevertheless, STAT5(C) Shown are CFSE dilution profiles of WT and DKI splenic CD4+ and CD8+ T cells in response to indicated cy
performed four times.
(D) IL-2Rb (CD122) and IL-7Ra (CD127) expression in DKI (blue lines) and WT (red lines) CD8+ T cells. This e
(E) Heat map of IL-2- and IL-15-regulated genes that are involved in cell cycle and proliferation whose express
data were from pooled splenic CD8+ T cells from WT (n = 10) and from DKI (n = 10) mice.
(F) Purified WT and DKI spleen T cells were cultured for 5 days with 500 U/ml of IL-2, viable CD8+ T cells (%)
time points as CD8+Annexin V7AAD cells. The data shown were derived from two independent experimen
(red) and DKI (blue) CD8+ T cells was determined by surface staining with anti-CD8 and intracellular staining
analyzed by flow cytometry. Values indicate MFI. Shown is one of two independent experiments.
(G and H) Defective homeostatic proliferation of DKI CD8+ T cells in lymphopenic hosts. CFSE dilution profi
recipients) and (H) (irradiated C57BL/6 recipients). The cell number (spleen) and percentage (lymph nodes) a
experiments in (F)–(H) were performed two times.
Immunity 36, 586–5tetramers are critical for normal NK cell
development and maintaining peripheral
CD8+ T cell and CD4+CD25+ T cell
numbers. Despite fairly normal T cell
development in DKI mice, DKI T cells
had profoundly diminished proliferation
to IL-2, IL-7, and IL-15 in vitro and
decreased survival upon cytokine with-
drawal. Moreover, in adoptive transfer
experiments, there was a defect in
homeostatic proliferation of CD8+
T cells, and correspondingly, there was
defective in vivo expansion of antigen-
specific DKI CD8+ T cells after LCMV
or Ad5 infection, although memory
CD8+ T cell development was similar in
WT and DKI mice. We also found that
STAT5 tetramers were required for
IL-2-induced IL-2Ra expression. Thefrequency and number of CD4+Foxp3+ Treg cells were similar
in DKI and WT mice, but the DKI Treg cells could not efficiently
suppress the development of colitis. Collectively, these data
establish a critical role of STAT5 tetramers in CD8+ T cell and
CD4+ Treg cell biology.tokine stimulations on day 5. This experiment was
xperiment was performed three times.
ion is significantly affected in DKI CD8+ T cells. The
after IL-2 withdrawal were determined at indicated
ts. As shown on the right, BCL2 expression in WT
with Ig control (gray) or anti-BCL2 antibodies and
les are shown in the top portions of (G) (Rag2/
re shown in the lower portions of (G) and (H). The
99, April 20, 2012 ª2012 Elsevier Inc. 595
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Figure 7. Decreased CD4+/CD25+ DKI T
Cells and Impaired Immune Suppressive
Function of DKI Treg Cells
(A and B) CD25 (IL-2Ra) and Foxp3 expression on
splenic CD4+ T cells from WT and DKI mice were
analyzed by flow cytometry. Shown are total cell
numbers (A) and FACS profiles (B). The numbers
indicate the percentage of CD4+ cells that were
also CD25+ or Foxp3+. CD25 expressing cells are
divided in low (bottom boxes), intermediate
(middle boxes), and high (top boxes) levels.
(C) Weight of mice during colitis development.
(D) Colitis scores of H&E stained colon sections
from two independent experiments.
(E) Representative histological sections of colons
with H&E staining.
(F and G) Shown are FACS profiles (F) and
graph (G) of the frequency and number of lamina
propria total TCRb+CD4+, TCRb+CD4+IFNg+, and
TCRb+CD4+IL-17A+ T cells from Rag2/ mice
adoptively transferred with WT RBhi, WTRBhi + WT
RBlo, or WT RBhi + DKI RBlo cells.
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Critical Role of STAT5 Tetramers In VivoWe also defined binding motifs for STAT5A and STAT5B
dimers and tetramers and identified the genes regulated by
dimers and tetramers. STAT5A and STAT5B tetramers bind to
divergent motifs with an optimal spacing of 11–12 between
GAS or GAS-like motifs, but with secondary optimal spacing of
6–7 and 15–17, indicating that STAT5 tetramers can bind to
sequences with a very broad range of spacing between tandem
GAS motifs. Such binding is presumably facilitated by the long
linker region between the N-domain and DNA binding domain
of STAT5 proteins (Leonard and O’Shea, 1998). Intriguingly,
the preferred spacings result in two tandemly linked GAS or
GAS-like motifs being separated by approximately half a helical
turn. It will be interesting to investigate whether the spacing and
motif rules for STAT5 also apply to other STAT proteins that can
bind as tetramers. In this regard, in the c-fos promoter, STAT1596 Immunity 36, 586–599, April 20, 2012 ª2012 Elsevier Inc.was observed to preferentially bind to
tandemly linked GAS motifs with a
spacing of 5, 10, and 15 nucleotides (Vin-
kemeier et al., 1996), although genome-
wide STAT1 tetramer sites are unknown.
Given that GAS motifs are semipanlin-
dromic 9 bp sequences, which are
slightly under a full helical turn in length,
rotating a STAT5 dimer approximately
half a helical turn along DNA could poten-
tially reconstitute the same topological
orientation to allow the N-domain interac-
tion between two dimmers; such an idea
could be further investigated.
Although STAT5A and STAT5B recog-
nize nearly identical dimer and tetramer
motifs, STAT5B tetramers appeared to
be more important than STAT5A tetra-
mers in regulating IL-2-induced gene
expression, suggesting distinctive as
well as overlapping functions for these
closely related transcription factors.Although the STAT4 N-domain is required for cytokine-induced
activation (Otaet al., 2004), tetramer-deficientmutantsofSTAT5A
and STAT5B can still bind as dimers and drive expression of
many genes. The critical role of STAT5 tetramers is underscored
by our identification of a range of genes whose induction is
abrogated or markedly decreased in the DKI T cells, including
Lta, Il24, Socs2, Cdk6, and Bcl2, many of which were not known
to be IL-2/STAT5 target genes. Recently, STAT5 tetramers were
suggested to mediate repression of the Ig k gene and other loci
in pro-B cells, and it was further suggested that repression might
be a preferential role for STAT5 tetramers (Mandal et al., 2011);
however, ourdata indicate thatSTAT5 tetramersarepreferentially
associated with gene activation in T cells. The DKI mice we have
generated will be valuable for clarifying the roles of STAT5
tetramers in other lineages as well, including B cells.
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Critical Role of STAT5 Tetramers In VivoOur studies also have implications for other STAT proteins that
can form tetramers. For example, analogous to STAT5, dimers
and tetramers of STAT1 may also differentially control gene
expression. Interestingly, multiple STAT5 binding sites, as
identified by ChIP-Seq analysis, are often located in 50, proximal
promoter, or intronic regulatory regions of STAT5 target genes.
This raises the possibility that N-domain-mediated tetrameriza-
tion or higher-order oligomerization of STAT5 could be a mecha-
nism by which widely separated STAT5 binding sites could be
juxtaposed to the regulatory regions by DNA looping to cooper-
atively control transcription; such a possibility warrants investi-
gation. Beyond STAT proteins, it is well known that a range of
eukaryotic transcription factors bind to semipalindromic DNA
sequences as dimers, but it is unknown whether they, like
STAT proteins, can additionally form tetramers to bind to tandem
lower-affinity sites. If tetramerization of such other factor(s)
indeed occurs, the lessons we have learned from STAT5 could
be applicable.
The activation of STAT family proteins by cytokines and
growth factors is vital in a broad range of innate and adaptive
immune responses and inflammation (Leonard and O’Shea,
1998), and the dysregulation of STAT3 and STAT5 is associated
with tumorigenesis (Bromberg et al., 1999; Chiarle et al., 2005;
Kelly et al., 2003; Yu et al., 2009). The DKI mice we have
generated will allow further evaluation of the roles of STAT5
tetramers in a range of pathological states. Our findings that
the absence of tetramerization does not compromise viability
and that only a minority of IL-2-modulated genes is regulated
by STAT5 tetramers together suggest that selectively targeting
tetramer formationwillmodulate only part of theactions of a cyto-
kine or growth factor, potentially allowing the development of
a new therapeutic approach to modulating immune responses,
controlling inflammation, and inhibiting tumor growth.
EXPERIMENTAL PROCEDURES
Detailed procedures for cell isolation and culture, plasmid constructs, muta-
genesis, nuclear extract preparation, EMSAs, knock-in mouse generation,
immunoblotting, RT-PCR, FACS analysis, in vitro proliferation and cell survival,
adoptive transfer experiments, Affymetrix GeneChip analysis, ChIP-Seq,
RNA-Seq, induction of colitis in Rag2 KOmice, and Ad5 infection experiments
are described in the Supplemental Experimental Procedures.
Mice
All protocols were approved by the NHLBI Animal Care and Use Committee
and followed NIH guidelines for using animals in intramural research. Six- to
twelve-week-old gender-matched mice were used.
Affymetrix GeneChip Data Analysis
Affymetrix GCOS version 1.4 was used for calculating the signal intensity and
percent present calls. Signal intensity values were transformed with an
adaptive variance-stabilizing, quantile-normalizing transformation termed
‘‘S10’’ (Munson, 2001) and subjected to a principal component analysis
(PCA) to detect outliers. One-way ANOVA with eight levels was applied to
the transformed data and the Student’s t test was used for comparing WT
and DKI samples. Genes were selected with 1.5 fold change (FC) at a false
discovery rate (FDR) of < 20%. Analysis was performed using the JMP statis-
tical software package (www.jmp.com; Cary, NC).
RNA-Seq Data Analysis
Sequence reads (single end 36 bp) were aligned against the RefSeq mouse
gene database (mm8) with ELAND pipeline. Raw counts that fell on exons ofeach gene were calculated. Genes that were differentially expressed were
identified with the statistical R package edgeR (Robinson et al., 2010). Genes
were identified as differentially expressed if adjusted p value < 1 3 105 and
fold-change > 1.5. The expression heatmaps were generated with the gplots
package in R.STAT5A and STAT5B DNA Binding Motif Discovery
Usingmodel-basedanalysis forChIP-Seq (MACS) (Zhanget al., 2008) to identify
statistically significant ChIP-Seq peaks, we compared STAT5A and STAT5B
data from WT and Stat5a-Stat5b DKI IgG controls and normalized tag counts
on the basis of the total ChIP-Seq tag count for each sample. Peaks were iden-
tified with MACS (see Supplemental Experimental Procedures) and data sets
and MACS results were summarized in Table S4. Within the peaks, STAT5A
and STAT5B binding sites were localized to a small region on the basis of the
highest fragment pileup, referred to as the ‘‘summit’’ inMACS.Weusedmultiple
EM for motif elicitation (MEME) (Bailey and Elkan, 1994) to ‘‘de novo’’ discover
consensusmotifs from theselectedbindingsites.Because of thecomputational
complexity in MEME algorithms, we chose the top 10% (with lowest p value) of
IL-2-induced STAT5A and STAT5B binding sites in WT cells to define
a consensus motif from a position specific probability matrix (PSPM) that
show observed frequencies of each base at each position. The selected
sequenceswere scannedwithPSPMand thosewith scores greater than a given
thresholdwere retained (FiguresS5FandS5G).Assumingatmostonemismatch
from the GAS consensus, the threshold is the total score in all positions sub-
tracted by the highest score at an individual position. Similarly, for two
mismatches, the threshold is the total score subtracted by the two highest indi-
vidual scores. In this fashion, 70 bp sequences containing GAS and/or GAS-like
motifs were identified, and these motifs were centered within each sequence
(Figure S5H). We normalized the total number of tags for WT and DKI data and
compared the number of STAT5A and STAT5B ChIP-Seq tags in the 70 bp
regions.Wedefinedsites ascandidates for tetramericbinding if the tagnumbers
inWT at a given location were >10 and theWT:DKI tag ratio was >1.5. Because
MEME cannot detect tandemly linked ‘‘gap-based’’ motifs, to discover STAT5
tetramer motifs, we first identified a GAS or GAS-like motif involved in tetramer
binding, then ‘‘ignored’’ it, and then used MEME to search for a second motif
within 35 bp on each side of the summit and determined the distance between
the centered and second motifs.Virus-Specific CD8+ T Cell Responses
Mice were injected i.p. with 2 3 105 pfu of LCMV Armstrong strain (Wherry
et al., 2003). Lymphocytes were isolated from spleen, liver, lung, and
peripheral blood (Barber et al., 2006). MHC class I tetramers conjugated
with APC were generated, and surface and intracellular cytokine staining
was performed as described (Wherry et al., 2003). Cells were analyzed
with an LSR II flow cytometer and FlowJo v.8.8 (Tree Star; Ashland, OR).
Dead cells were removed by gating on Live/Dead Near IR (Invitrogen,
Carlsbad, CA).Inflammation Score and Cytokine Production in LPMCs
At the end-point of the study (9 weeks after adoptive transfer), colonic inflam-
mation was assessed by a modification of scoring systems (Jenkins et al.,
1997) inwhichH&E stained cross-sections of colons are graded for crypt archi-
tecture abnormalities such as shortening and distortion (0–3), lamina propria
cellularity (0–3), and epithelial abnormalities such as goblet cell loss, epithelial
hyperplasia, erosions, and ulceration (0–3). Changeswere also scored as to the
percent area of involvement according to the scale 1 = 25%, 2 = 50%, and 3 =
75%–100%.
Lamina propria mononuclear cells (LPMCs) were cultured in complete
RPMI 1640 medium containing 50 ng/ml PMA, 500 ng/ml calcium ionophore,
and 1 mg/ml GolgiStop (BD Biosciences, San Jose, CA) for 5 hr before staining
with fluorescent-labeled antibodies to TCRb, CD4, IFNg, and IL-17A and flow
cytometer analysis with FlowJo software.Statistical Analysis
Statistics was performed with Prism4 software (GraphPad Software, Inc., La
Jolla, CA).Immunity 36, 586–599, April 20, 2012 ª2012 Elsevier Inc. 597
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